Back to search
PSR Ovarian Cancer With a BRCA Mutation
Clinical trial pipeline · Data from ClinicalTrials.gov
See which PSR Ovarian Cancer With a BRCA Mutation trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which PSR Ovarian Cancer With a BRCA Mutation trials you may qualify forThis is a single-arm, open label, expanded access program to provide access to olaparib tablets for relapsed high-grade epithelial ovarian cancer patients (incl…
Olaparib administered as monotherapy in the maintenance setting improves progression free survival compared to placebo in patients whose tumours carry loss of f…